Want to see FR:GNFT full AI Analyst Report?
Genfit (GNFT) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Soc, Vs-01 On Top Of Soc (Active Treatment Group) | Decompensated Cirrhosis, Hepatic Encephalopathy, Acute On Chronic Liver Failure (Aclf) | Phase II | Terminated | A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy | May 07, 2025 | ― |
| Vs-01 On Top Of Soc, Soc (Control Group) | Acute-On-Chronic Liver Failure, Ascites | Phase II | Terminated | Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)® | Jun 02, 2023 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Soc, Vs-01 On Top Of Soc (Active Treatment Group) | Phase II | Decompensated Cirrhosis, Hepatic Encephalopathy, Acute On Chronic Liver Failure (Aclf) | Terminated | A Study to See if an Investigational Medicine Called VS-01 Can Help and How Safe it is in the Treatment of Patients With Overt Hepatic Encephalopathy | May 07, 2025 | ― |
| Vs-01 On Top Of Soc, Soc (Control Group) | Phase II | Acute-On-Chronic Liver Failure, Ascites | Terminated | Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)® | Jun 02, 2023 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Genfit SA (FR:GNFT) have in its pipeline
Genfit FR:GNFT is currently developing the following drugs: Soc, Vs-01 On Top Of Soc (Active Treatment Group), Vs-01 On Top Of Soc, Soc (Control Group). These drug candidates are in various stages of clinical development as the company works toward FDA approval.